Cytori’s Stem Cell Therapy for Burns Wins U.S. Contract

Cytori Therapeutics Inc., a biotechnology company with $10 million in annual revenue, rose the most in about a year after the company won a $4.7 million U.S. government contract to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.